08.10.2021 RHÖN-KLINIKUM Aktiengesellschaft  DE0007042301

DGAP-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Adjustment of Guidance for the Financial Year 2021


 

DGAP-Ad-hoc: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Change in Forecast
RHÖN-KLINIKUM Aktiengesellschaft: Adjustment of Guidance for the Financial Year 2021

08-Oct-2021 / 15:57 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



Publication of Inside Information according to Article 17 Market Abuse Regulation (MAR)


Bad Neustadt a. d. Saale, 8 October 2021

Adjustment of Guidance for the Financial Year 2021

Due to the positive development of the business in the first nine months of the financial year 2021 the management board of RHÖN-KLINIKUM Aktiengesellschaft decided today to adjust the current guidance for the Earnings before interest, taxes, depreciation and amortisation (EBITDA) for the financial year 2021 (between € 72.5 million and € 82.5 million). For the financial year 2021 the management board of the Company now expects an EBITDA between € 92 million and € 102 million.

The guidance for the revenues in the amount of € 1.4 billion within a range of +/- 5 % remains unchanged.

This guidance reflects the regulatory legislative interventions, such as the German regulation for the threshold for nursing staff (Pflegepersonaluntergrenzen-Verordnung - PpUGV) and the German nursing staff reinforcement act (Pflegepersonal-Stärkungsgesetz - PpSG), which have become even tighter. In addition, it should be noted that the guidance is subject to uncertainties in connection with the course of the COVID-19 pandemic and any regulatory legislation affecting the remuneration structure in 2021.


Contact:

RHÖN-KLINIKUM AG
Group Head of Accounting, Tax, Controlling, Finance and Investor Relations
Igor Levit
T. +49 9771 65-12210 | [email protected]

RHÖN-KLINIKUM AG
Head of Investor Relations and Treasury
Julian Schmitt
T. +49 9771 65-12250 | [email protected]


RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale


08-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: RHÖN-KLINIKUM Aktiengesellschaft
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: [email protected]
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1239569

 
End of Announcement DGAP News Service

1239569  08-Oct-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1239569&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.510,00
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 107,50
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 41,00
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,72
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 35,00
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,32
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 0,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,51
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 9,850 Halten 659,58
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
13,68 27,55 0,48 16,98
KBV KCV KUV EV/EBITDA
0,53 15,97 0,46 6,93
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,15 1,52 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 09.11.2023 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-2,85% -13,84% -1,50% -25,38%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM Aktiengesellschaft  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK